Balanoposthitis
Conditions
Interventions
experimental group:Clioquinol cream
control group:placebo
Sponsors
The First Affiliated Hospital of China Medical University
Eligibility
Sex/Gender
Male
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Chinese men over 18 years old; 2. The patients with balanitis were diagnosed clinically; 3. There were no other skin diseases or systemic diseases that could affect the detection; 4. Patients who have informed consent to the purpose and content of the study and can follow up as required.
Exclusion criteria
Exclusion criteria: 1. Patients who have systematically used glucocorticoids and / or immunosuppressants in the last month; 2. In recent 2 weeks, antibiotics, corticosteroids or other anti-inflammatory drugs have been used outside the prepuce glans area; 3. Underwent organ resection (kidney, lung, spleen, liver......), organ transplantation, a history of consciousness or sequelae caused by craniocerebral trauma within the past 5 years; 4. Patients with chronic diseases such as hypertension, diabetes, liver and kidney failure or receiving long-term treatment; 5. Patients with skin diseases affecting the measurement of external genitalia, such as glans cricoides, lichen sclerosus, lichen sclerosus (glans obliterans), erythematous hyperplasia, pemphigus, lichen planus, Bowen's disease, psoriasis, psoriasis, contact allergy, fixed drug eruption and other diseases in the test site; 6. Patients who are sensitive or allergic to the drugs used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 16s rRNA; | — |
Secondary
| Measure | Time frame |
|---|---|
| skin barrier function;severity score; | — |
Countries
China
Contacts
Public ContactGao Xinghua
The First Affiliated Hospital of China Medical University
Outcome results
None listed